Feb 20, 2026 08:30AM
Feb 20, 2026 08:30AM
Jan 22, 2026 08:45AM
Jan 22, 2026 08:45AM
Jan 9, 2026 08:45AM
Jan 9, 2026 08:45AM
Dec 2, 2025 08:32AM PDS Biotech schedules FDA meeting on accelerated approval pathway
Dec 2, 2025 08:30AM
Nov 13, 2025 07:30AM
Nov 11, 2025 03:31PM
Nov 11, 2025 03:31PM
Oct 29, 2025 08:37AM
Oct 29, 2025 08:37AM
Jun 9, 2025 08:00AM PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC
Jun 2, 2025 08:03AM
Jun 2, 2025 08:00AM
May 14, 2025 07:30AM
Mar 28, 2025 06:40AM
Mar 27, 2025 07:30AM
Mar 13, 2025 08:00AM
Mar 7, 2025 08:45AM PDS Biotechnology (PDSB) Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
Mar 7, 2025 08:45AM
Feb 26, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 5, 2025 08:02AM
Feb 5, 2025 08:00AM
Dec 3, 2024 08:00AM PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
Nov 14, 2024 08:00AM
Nov 14, 2024 08:00AM
Oct 3, 2024 06:59AM
Oct 2, 2024 08:02AM
Oct 2, 2024 08:00AM
Sep 16, 2024 07:01AM
Sep 16, 2024 07:00AM PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
Aug 13, 2024 08:00AM
Aug 1, 2024 07:45AM
Aug 1, 2024 07:45AM
Mar 27, 2024 07:32AM
Mar 27, 2024 07:30AM
Nov 28, 2023 08:31AM
Nov 28, 2023 08:30AM Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
Nov 14, 2023 07:30AM
Oct 23, 2023 08:07AM
Oct 23, 2023 08:00AM
Oct 3, 2023 07:01AM
Oct 3, 2023 07:00AM
Sep 13, 2023 08:00AM
Aug 14, 2023 07:30AM PDS Biotech Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 14, 2023 07:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All